Intraperitoneal Injection of Cisplatin Induces Nausea-Like Responses without Vomiting in Chicks (Gallus gallus domesticus) Authors: Kaoru Nakamura, Sakirul Khan, Mark A. Cline, Tetsuya Tachibana Published: 2026 ABSTRACT AbstractCisplatin is an anti-cancer drug that causes nausea and vomiting as adverse effects. Cisplatin-induced responses have been widely used to investigate the mechanisms underlying nausea and vomiting in several mammalian species. Because nausea and vomiting are caused by a variety of factors, including disease and stress, clarification of these mechanisms would contribute to improving animal welfare in poultry production. However, the effects of cisplatin in chickens have not been well documented. Thus, we examined whether intraperitoneal (IP) injection of cisplatin caused nausea and vomiting in chicks. IP injection of cisplatin decreased food intake, voluntary activity, and the passage of food from the crop. Moreover, cisplatin tended to increase plasma corticosterone concentrations and decreased plasma glucose concentration. As these effects are consistent with nausea-related responses observed in mammals, cisplatin might also induce nausea in chicks. However, cisplatin did not induce vomiting in any experiments. Furthermore, cisplatin slightly decreased the pH of the crop contents and phenol red gavaged into the proventriculus refluxed into the crop, although these effects were not considerable. Thus, the lack of substantial reflux from the proventriculus prevented vomiting in chicks after cisplatin injection. Introduction Vomiting, also known as emesis, is the forceful expulsion of stomach contents through the mouth or nose. Nausea is a subjective sensation of discomfort and unease typically perceived as the urge to vomit. Because nausea and vomiting are non-specific symptoms caused by various factors, including gastrointestinal disorders, motion, food poisoning, and stress[1], clarification of the mechanisms underlying nausea and vomiting would contribute to the early detection of these factors and improve animal welfare in poultry production. Cisplatin is a platinum-containing chemotherapeutic drug that is widely used for cancer treatment. One of the major side effects is the induction of nausea and vomiting[2,3,4]. Because of this property, cisplatin has been used extensively to study the mechanisms of nausea and vomiting. Indeed, cisplatin induces nausea and vomiting in dogs[5,6], ferrets[7,8], cats[9], and house musk shrews[10,11]. Although rodents and goats are incapable of vomiting[1,12], cisplatin decreases food intake[13], voluntary activity[14,15], and food passage from the digestive tract[16] and increases circulating glucocorticoid concentrations in these species[17,18]. Cisplatin also increases pica behavior, a common index of nausea, in rats[13]. Thus, cisplatin has been shown to induce nausea, even in non-vomiting mammals. In contrast to that in mammals, information on the effects of cisplatin in birds is limited. Among avian species, cisplatin has been shown to induce vomiting in pigeons, which have often been used to study its effects[19]. Since pigeons possess a specialized crop that secretes pigeon milk, which is regurgitated to feed their chicks[20], pigeons are able to reflux the content of the digestive tract after cisplatin treatment. However, the emetic effects of cisplatin on chickens, a major poultry species worldwide, have not been well studied. In chickens, copper sulfate, another emetic agent, causes retching, which is a retrograde movement without vomiting[21,22], suggesting that chickens may lack the ability to vomit. Even though cisplatin does not induce vomiting in chickens, as opposed to pigeons, it may still cause nausea, as has been observed in rodents and goats. However, whether cisplatin induces nausea has not yet been clarified in chickens. Therefore, the purpose of the present study was to determine whether an intraperitoneal (IP) injection of cisplatin induced nausea-like responses and/or vomiting in chicks (Gallus gallus domesticus). To assess nausea, the effects of cisplatin on food intake, voluntary activity, food passage through the digestive tract, and plasma corticosterone concentration were examined. In addition, we investigated whether cisplatin caused backflow of the proventriculus and gizzard contents. Materials and Methods Animals Day-old male layer chicks (Gallus gallus domesticus, White Leghorn) were obtained from a local hatchery (Minami Iyo Yokei, Iyo, Japan) and raised in a room maintained at 30 °C, with continuous lighting. A commercial diet (crude protein: 23%, metabolizable energy: 3050 kcal/kg; JA Zen-Noh Kumiai Feed Co. Ltd., Tokyo, Japan) and water were provided ad libitum. Chicks were transferred to experimental cages for at least two days before each experiment for acclimation and were housed individually one day before the experiment. Body weight was measured before the experiment, and chicks were then assigned to experimental groups to ensure similar body weights among groups. All animal experiments were approved by the Committee of Animal Care and Use of Ehime University, Japan (No. 08-o5-10), and conducted in accordance with the Ehime University Animal Experiment Regulations. Drugs and IP injections All injections were given between 0500 and 1200. Cisplatin (FUJIFILM Wako Pure Chemical Co., Osaka, Japan) was dissolved in sterile saline at 70 °C, as described previously[19]. For the IP injection, 0.2 mL of cisplatin solution was injected into the abdominal cavity. Control chicks received the same volume of sterile saline. Experiment 1: Effect of cisplatin treatment on vomiting and food intake Twenty-nine 6-day-old chicks were IP injected with 0 (control, vehicle only), 0.06, or 0.3 mg cisplatin under ad libitum feeding conditions. Cisplatin doses were based on a previous study in pigeons[19]. After the injection, chicks were returned to their cages, and a sheet of white paper was placed under each cage to monitor the incidence of vomiting. Subsequently, a pre-weighed feeder was provided to chicks and food intake was measured at 1, 2, 4, 6, and 12 h after injection using a digital balance with an accuracy of 1 mg. The incidence of vomiting was verified by inspecting the white paper at each food intake measurement. Experiment 2: Effect of cisplatin treatment on vomiting and voluntary activity Twelve 7-day-old chicks fed ad libitum were IP injected with 0 (control) or 0.3 mg cisplatin. Subsequently, chicks were returned to their cages and a sheet of white paper was placed under each cage to monitor vomiting. Voluntary activity was recorded every 30 min for 6 h using a passive pyroelectric infrared detector (NS-AS02; Neuroscience Inc., Tokyo, Japan) connected to a DAS system 64 (Neuroscience Inc.). After completing the activity recording, vomiting was assessed by checking the white paper placed under the cage. Experiment 3: Effect of cisplatin treatment on crop emptying The crop emptying rate was measured based on a previously reported method[23]. Twenty-five 6-day-old chicks were food-deprived for 13 h to empty residual ingesta from the crop, and then IP injected with 0 (control), 0.06, or 0.3 mg cisplatin. After an additional 2 h of food deprivation, chicks were gavaged with approximately 2 g of feed slurry into the crop. The feed slurry was prepared by mixing powdered diet with distilled water at a ratio of 40:60 (w/w). After gavage, chicks were returned to their individual cages and both feed and water were withheld. A sheet of white paper was placed under each cage to monitor vomiting. Two hours after gavage (4 h after cisplatin injection), chicks were euthanized by carbon dioxide inhalation. The crop was exposed, the upper and lower esophagi were clamped, and the crop was excised. The total crop content was recovered and dried at 55 °C for 48 h, followed by air drying for an additional 24 h. The air-dried slurry was then weighed using a digital balance with a precision of 1 mg. The wet slurry weight was then calculated based on the dry weight. The amount of slurry emptied from the crop through the lower esophagus was calculated by subtracting the slurry weight within the crop from the administered slurry weight. The crop emptying rate was expressed as the percentage of slurry emptied relative to the amount administered. During the experiment, a sheet of white paper was placed under each cage to monitor vomiting. Experiment 4: Effect of cisplatin treatment on plasma corticosterone and glucose levels Thirty-two 5-day-old chicks were assigned to two treatment groups according to injection (control or 0.3 mg cisplatin) and further subdivided according to the timing of blood collection (2 or 6 h after the injection). At 2 or 6 h after the IP injection, food intake was measured as described in Experiment 1. Immediately after measuring food intake, blood samples were collected from the jugular vein using heparin as an anticoagulant. Blood samples were centrifuged (9,000 × g at 4 °C for 5 min), and plasma was collected and stored at −80 °C until analysis. Plasma corticosterone and glucose concentrations were measured using commercial assay kits (AsayPro LLC, St. Charles, MO, USA and Wako Pure Chemical Industries, Ltd., Osaka, Japan, respectively), according to the manufacturer’s instructions. Throughout the experiment, a sheet of white paper was placed under each cage to monitor vomiting. Experiment 5: Cisplatin-induced reflux from the proventriculus to the crop Seventeen 8-day-old chicks were fasted for 15 h and then IP-injected with 0 (control) or 0.3 mg cisplatin, after which fasting was continued for an additional 2 h. Feed slurry was then gavaged into the crop as noted in Experiment 3. A sheet of white paper was placed under each cage to monitor vomiting. Feed and water were withheld for an additional 2 h, after which the crop contents were collected as in Experiment 3. To assess reflux from the proventriculus, the pH of the crop contents was measured using a pH meter (LAQUAtwin; Horiba Ltd., Kyoto, Japan). In a separate experiment, twenty-eight 5-day-old chicks were fasted for 15 h and IP injected with 0 (control) or 0.3 mg cisplatin, followed by an additional 2 h of food deprivation. Subsequently, 2% carboxymethyl cellulose containing 2% phenol red was directly injected into the proventriculus using a stainless steel gastric tube with a silicone-coated tip. Chicks were returned to their cages, and a sheet of white paper was placed under each cage to monitor vomiting. Food and water were withheld for 30 min. The crop was then excised, placed in centrifuge tubes, and stored at −30 °C until analysis. Phenol red was extracted from the crop contents in 1 mL of sterile saline with gentle agitation for 1 h. Samples were centrifuged (2000 × g at 25 °C for 2 min), and 500 µL of the supernatant was transferred to another tube. Subsequently, 100 µL 20% trichloroacetic acid was added to precipitate proteins. After centrifugation (9100 × g at 4 °C for 20 min), 250 µL of the supernatant was transferred to another tube, and 400 µL 0.5 M sodium hydroxide was added. The absorbance was measured at 550 nm using a microplate reader (Bio-Rad, Hercules, CA, USA). Statistical analysis Data from Experiments 1 and 2 were analyzed using a two-way mixed-effects model of analysis of variance (ANOVA), with injection and time as fixed factors. Post hoc comparisons at each time point were performed using the Tukey–Kramer test or Student’s t-test, as appropriate. Data from Experiment 3 were analyzed using a one-way ANOVA followed by the Tukey–Kramer test. Data from Experiments 4 and 5 were analyzed using the Student’s t-test, and the Mann–Whitney U-test was used when assumptions of normality or homogeneity were not met. Data are expressed as means ± the standard error of the mean (SEM), and statistical significance was set at P < 0.05. The numbers of chicks in each experimental group are indicated in the figure legends. Results Experiment 1: Effect of cisplatin treatment on vomiting and food intake None of the chicks injected with cisplatin vomited during the 12-h observation period. Cisplatin treatment significantly affected food intake [F(2,26) = 25.6, P < 0.05], and a significant interaction between cisplatin treatment and time was observed [F(4,104) = 25.5, P < 0.05] (Fig. 1). Chicks injected with 0.06 mg cisplatin exhibited significantly less food intake 6 h after injection, whereas injection of 0.3 mg cisplatin significantly reduced food intake 2 h after injection. Effect of intraperitoneal (IP) injection of cisplatin on food intake of ad libitum-fed chicks. The number of chicks in 0 (control), 0.06, and 0.3 mg cisplatinwas 10, 10, and 9, respectively. Data are expressed as means ± the standard error of the mean (SEM). Groups with different letters are significantly different at each time (P < 0.05). Experiment 2: Effect of cisplatin treatment on vomiting and voluntary activity Consistent with the results of Experiment 1, cisplatin injection did not cause vomiting during the observation period. Voluntary activity was significantly reduced by cisplatin treatment [F(1,9) = 16.1, P < 0.05], whereas no significant interaction was observed between cisplatin and time [F(11,99) = 1.5, P = 0.13] (Fig. 2). Cisplatin injection significantly reduced voluntary activity 2.5 h after injection, but not at 4.5 and 5.5 h. Effect of intraperitoneal (IP) injection of cisplatin on voluntary activity in chicks. The number of chicks was 5 in each group. Data are expressed as means ± the standard error of the mean (SEM). Asterisks indicate a significant difference from the 0 mg control group (P < 0.05). Experiment 3: Effect of cisplatin treatment on crop emptying No chicks vomited following cisplatin injection. The amount of feed slurry administered did not differ among groups (control, 2.21 ± 0.02 g; 0.06 mg cisplatin, 2.22 ± 0.02 g; 0.3 mg cisplatin, 2.19 ± 0.05 g). Chicks injected with cisplatin displayed a greater amount of slurry remaining in the crop than that of the controls (Fig. 3). Thus, cisplatin treatment reduced the crop-emptying rate in a dose-dependent manner (Fig. 3). Effect of intraperitoneal (IP) injection of cisplatin on the crop emptying rate in chicks. The number of chicks in 0 (control), 0.06, and 0.3 mg cisplatinwas 8, 10, and 8, respectively. Data are expressed as means ± the standard error of the mean (SEM). Groups with different letters are significantly different (P < 0.05). Experiment 4: Effect of cisplatin treatment on plasma corticosterone and glucose levels Cisplatin injection significantly reduced food intake at both time points, consistent with the results of Experiment 1 (Fig. 4). Two hours after injection, plasma corticosterone concentrations were not affected by cisplatin treatment (Fig. 4). At 6 h, corticosterone concentrations increased in cisplatin-injected chicks, but the differences were not significant (P = 0.09). Cisplatin treatment significantly reduced the plasma glucose concentrations at both time points. Effect of intraperitoneal (IP) injection of cisplatin on food intake, and plasma concentrations of corticosterone and glucose in chicks. In the both times, the number of chicks was 8 in each group. Data are expressed as means ± the standard error of the mean (SEM). Asterisks indicate significant differences from the 0 mg control group (P < 0.05). Experiment 5: Cisplatin treatment induced reflux from the proventriculus to the crop No vomiting was observed in any chicks. Cisplatin treatment tended to reduce the pH of the crop contents; however, the effect was not significant (Fig. 5A). In the phenol red experiment, cisplatin treatment did not cause chickens to vomit phenol red onto the white paper; however, cisplatin tended to increase the phenol red concentration in the crop (Fig. 5B). Reflux from the proventriculus to the crop after intraperitoneal (IP) injection of cisplatin. (A) Effect of IP cisplatin injection on pH in the crop content. The number of chicks in the 0 and 0.3 mg cisplatin groups was 7 and 10, respectively. (B) Concentration of phenol red in the crop at 30 min after the gavage of phenol red into the proventriculus. The number of chicks in the 0 and 0.3 mg cisplatin groups was 10 and 14, respectively. Data are expressed as means ± the standard error of the mean (SEM). Discussion Cisplatin treatment induces anorexia[13], hypoactivity[14,15], a reduction in food passage from the digestive tract[16], and increases glucocorticoid secretion in rats and goats[17,18]. In the present study, chicks injected with cisplatin exhibited reduced food intake (Fig. 1), voluntary activity (Fig. 2), and crop-emptying rate (Fig. 3). Moreover, cisplatin treatment also tended to increase plasma corticosterone concentrations in chicks (Fig. 4). These responses are similar to those reported in mammals[13,14,15,16,17,18], suggesting that the effects of cisplatin are conserved across mammals and birds. As these behavioral and physiological changes are commonly associated with nausea-like responses, cisplatin is likely to induce nausea in chicks. Although cisplatin treatment tended to increase plasma corticosterone levels, it reduced plasma glucose concentrations (Fig. 4). This finding contradicts the hyperglycemic effect typically associated with elevated corticosterone levels in chicks[24]. The reduction in plasma glucose was likely attributable to decreased glucose absorption from the small intestine caused by reduced food intake (Fig. 1) and an impaired crop-emptying rate (Fig. 3). Corticosterone was likely released to maintain plasma glucose levels, but was not sufficient to increase glucose levels. Food intake, locomotor activity, and gastrointestinal motility are regulated by the central nervous system[25]; therefore, cisplatin treatment likely affects central nervous system activity in chicks. In cats, intracerebroventricular injection of cisplatin induces vomiting more rapidly than that of IP cisplatin injection[26]. Peripheral injection of cisplatin induces Fos-like immunoreactive neurons in the nucleus tractus solitarius (NTS) and area postrema (AP) of the medulla oblongata in ferrets and house-musk shrews[27,28]. In rats, cisplatin induces Fos-like immunoreactive neurons in the NTS, AP, central amygdala (CeA), and bed nucleus of the stria terminalis[29]. These cisplatin-induced Fos responses in the NTS and CeA are attenuated by vagotomy in rats[29], and cisplatin-induced vomiting is reduced by vagotomy in house-musk shrews and pigeons[11,19]. These findings suggest that afferent vagal nerves partly mediate the effects of cisplatin treatment. Because cisplatin does not readily cross the blood–brain barrier in mammals[30], it likely activates the central nervous system via brain regions that lack this barrier, such as the AP. Further studies are required to clarify whether the central nervous system, particularly the medulla oblongata, mediates cisplatin-induced nausea-like effects in chicks. Since cisplatin-induced reduction in food intake (Fig. 1) and voluntary activity (Fig. 2) occurred 2 h or later, cisplatin treatment is expected to exert its effect via bioactive molecules. Among bioactive molecules, 5-hydroxytryptamine (5-HT) is a strong candidate for mediating cisplatin activity. Cisplatin-induced vomiting is blocked by 5-HT3 receptor antagonists in cats and humans[4,26]. In addition, p-chlorophenylalanine, an inhibitor of tryptophan hydroxylase that suppresses 5-HT synthesis, attenuates cisplatin-induced vomiting in ferrets and pigeons[8,19]. Moreover, cisplatin-induced anorexia and inhibition of gastric emptying are attenuated by 5-HT3 receptor antagonists in rats[16,31]. In chicks, intracerebroventricular injection of 5-HT decreases food intake[32], and IP injection of 5-HT reduces crop emptying[33], similar to the effects of cisplatin. Because these effects closely resemble those induced by cisplatin, 5-HT might mediate cisplatin activity in chicks. Dopamine is another potential mediator, as dopamine receptor antagonists reduce cisplatin-induced vomiting in dogs, ferrets, and house-musk shrews[5,7,10]. In rodents, cisplatin-induced anorexia is mediated by glucagon-like peptide-1[34] and oxytocin[35]. In chicks, glucagon-like peptide-1 and mesotocin, the avian homolog of oxytocin, are anorexigenic peptides[36,37], and an IP injection of glucagon-like peptide-1 inhibits crop emptying[38]. Therefore, these peptides may contribute to cisplatin-induced anorexia in chicks. Future studies should clarify the specific bioactive molecules responsible for the cisplatin-induced effects in chicks. In contrast to nausea-like responses, no chicks vomited throughout the study. Additionally, although quantitative behavioral scoring was not performed, vomit-associated behaviors were not observed. We attempted to examine the effects of a higher dose of cisplatin (0.6 mg). However, it caused death in 4 of the 20 chicks at 12 h or later after injection in a preliminary experiment (data not shown), as reported previously in rats[14]. Therefore, similar to rodents and goats, chickens, at least at an early developmental stage, do not vomit in response to cisplatin injection[1,12,18]. In mammals, several rodent species, such as mice, rats, guinea pigs, nutrias, and beavers, are unable to vomit when exposed to emetic agents[12]. A comprehensive comparative study demonstrated that rodents possess reduced diaphragmatic musculature, a longer intra-abdominal esophagus, and a stomach lacking a funnel shape. Thus, rodents exhibit only emetic-like responses, such as esophageal contraction and phrenic nerve bursting, compared to that of species that vomit[12]. These findings suggest that non-emetic animals lack the key anatomical and neurophysiological features of the diaphragm and digestive tract required for vomiting. Birds lack a diaphragm[39], which is essential for vomiting in mammals[40]. In addition, the avian stomach structure, comprising the proventriculus and gizzard, differs markedly from that of mammals[20]. These anatomical features may explain why chicks did not vomit in the present study. As most birds possess a crop along the esophagus[20], it is possible that even if stomach contents reflux after cisplatin injection, they are retained within the crop. Because the pH of the stomach contents is low (proventriculus, 5.17 ± 0.26; gizzard, 3.65 ± 0.31; preliminary experiment, n = 4), the pH of crop contents was measured. Cisplatin treatment decreased the pH of the crop contents without a substantial change in absolute values (Fig. 5). Additionally, phenol red injected into the proventriculus refluxed into the crop (Fig. 5). However, the amount of phenol red detected in the crop was substantially lower than that detected in the proventriculus. These results suggest that cisplatin treatment facilitates reflux of stomach contents; however, there is minimal reflux in chicks. Cisplatin treatment induces vomiting in pigeons[19]. Pigeons also experience vomiting after intra-crop injection of copper sulfate; however, this treatment does not induce vomiting in adult chickens[21]. Pigeons produce crop milk during the breeding season and regurgitate it to feed their chicks[20]. Additionally, some avian species are capable of expelling stomach contents; for example, owls expel indigestible materials from their gizzards via reverse peristalsis[41]. Collectively, these observations indicate that digestive anatomy and emetic ability appear to be diverse among birds, as they are among mammals. In conclusion, the present study demonstrated that cisplatin treatment induced nausea-like responses, but not vomiting, in chicks. These results further support the hypothesis that chickens are non-emetic animals. The reduction in food intake, activity, and food passage after crop emptying would not be only observed during nausea. Specific responses to nausea in birds remain unclear. Further studies will clarify the mechanisms underlying cisplatin-induced nausea-like responses in chickens, thereby contributing to the early detection of nausea-inducing factors, such as stress, food poisoning, and gastrointestinal disorders. Ethical Approval All animal experiments were approved by the Committee of Animal Care and Use of Ehime University, Japan (No. 08-o5-10), and conducted in accordance with the Ehime University Animal Experiment Regulations. Funding The authors received no specific grant for the research of this article. Author Contribution Kaoru Nakamura designed and conducted the experiments, and analyzed the data; Sakirul Khan designed the experiments, discussed the results, and edited the paper; Mark A. Cline discussed the results and edited the paper; Tetsuya Tachibana conceived the present study and experimental design, conducted experiments, analyzed the data, and wrote the paper. Conflicts of Interest The authors declare no conflicts of interest. Declaration of AI and AI-assisted Technologies The authors declare that they did not use AI or AI-assisted technology in this study.